Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Debt Ratio (2021 - 2026)

bioAffinity Technologies has reported Debt Ratio over the past 6 years, most recently at 0.0 for Q1 2026.

  • Quarterly Debt Ratio fell 43.58% to 0.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.0 through Mar 2026, down 43.58% year-over-year, with the annual reading at 0.0 for FY2025, 21.66% up from the prior year.
  • Debt Ratio was 0.0 for Q1 2026 at bioAffinity Technologies, up from 0.0 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.04 in Q3 2022 and troughed at 0.0 in Q1 2024.
  • The 5-year median for Debt Ratio is 0.0 (2023), against an average of 0.01.
  • Year-over-year, Debt Ratio plummeted 85.85% in 2022 and then soared 203.32% in 2025.
  • A 5-year view of Debt Ratio shows it stood at 0.02 in 2022, then crashed by 76.91% to 0.0 in 2023, then tumbled by 35.06% to 0.0 in 2024, then rose by 21.66% to 0.0 in 2025, then rose by 29.95% to 0.0 in 2026.
  • Per Business Quant, the three most recent readings for BIAF's Debt Ratio are 0.0 (Q1 2026), 0.0 (Q4 2025), and 0.0 (Q3 2025).